The Society of Cardiovascular Computed Tomography (SCCT) has announced a Clinical Trials and Registries Research Award. Researchers who meet the eligibility requirements are encouraged to submit their trial for consideration by the May 8, 2023 deadline. Photo credit: Getty Images
April 17, 2023 — The Society of Cardiovascular Computed Tomography (SCCT) has announced a SCCT Clinical Trials and Registries Research Award. According to a summary news brief issued by the association on April 17, this inaugural award will recognize and support clinical trials that use CCTA and/or CCTA-based analyses to detect atherosclerotic burden in the diagnosis and treatment of coronary artery disease, and demonstrate a positive impact on patient outcomes.
Researchers who meet the eligibility requirements detailed below are encouraged to submit their trial for consideration by the May 8, 2023 deadline.
- Prospective trials, prospective or retrospective large registries that investigated CCTA-based analyses of atherosclerotic burden.
- Primary trial/registry analyses or novel/impactful secondary analyses of previously published studies. Substantial new analyses with novel hypotheses are required.
- Results demonstrating the impact of CCTA-based atherosclerotic burden analysis on clinical outcomes, quality of care, or clinical practice changes.
- Results were not previous published or presented in part or entirety in the past.
Authors are encouraged to submit the results of their work to the Journal of Cardiovascular Computed Tomography (JCCT).
The winner will be notified by June 1, 2023, and will receive $10,000 in prize money, as well as full professional SCCT membership for one year, complimentary registration to SCCT2023, July 28-20 in Boston, MA, and travel support, and a commemorative plaque. Additionally, notes the SCCT update, the winner will be invited to make a 20-minute presentation during the Opening Session of the SCCT Annual Scientific Meeting (SCCT ASM) on Friday, July 28, 2023.
The inaugural SCCT Clinical Trials and Registries Research Award is supported by Cleerly, a digital healthcare company focused on heart disease. The company’s clinically-proven, AI-based digital care platform works with coronary computed tomography angiography (CCTA) imaging to precisely identify and define atherosclerosis earlier, helping clinicians to provide personalized, life-saving treatment plans for all patients throughout their care continuum.
For more information: www.scct.org